BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 10, 2001
View Archived Issues
Argatroban sNDA filed for HIT patients undergoing PCI
Read More
Ivax joins forces with Harvard Medical School affiliate in CF research
Read More
SR Pharma and Corixa broaden autoimmune diseases agreement
Read More
Solvay launches Teveten in Canada for hypertension
Read More
United Therapeutics forms new company focused on gene therapy
Read More
Phase III results with Metvix PDT for primary BCC reported as positive
Read More
Aminoacyl-tRNA synthetase pursued as potential target for new antibacterial agents
Read More
Nonacylguanidine compound characterized as potent and selective NHE1 inhibitor
Read More
Prospective trial compares efficacy of teprenone and rabeprazole against NSAID-induced GI lesions
Read More
Cholesterol-lowering effects of Sch-48461 demonstrated in primary hypercholesterolemia
Read More
DITPA improves abnormal SR Ca2+ transport and protein expression following myocardial infarction
Read More
Expanded phase III trial program in bipolar disorder announced for Seroquel
Read More
Cor, Schering-Plough and Genentech to copromote Integrilin, TNKase and Activase
Read More
Lorus Therapeutics' Virulizin shows better antitumor activity than Taxol in preclinical studies
Read More
Major functional genomics collaboration in oncology formed in Europe
Read More
Roche and Genentech enter agreement with OSI to develop and commercialize OSI-774
Read More
AVI BioPharma receives grant to develop NeuGene-based prostate cancer therapeutics
Read More
Aventis sells U.S. and Canadian rights to Cardizem products to Biovail
Read More
Successful completion of phase I trial with Isotechnika's new immunosuppressant
Read More
Ligand receives milestone payment from Wyeth-Ayerst; TSE-424 development continues
Read More
GnRH receptor antagonists designed by Neurocrine Biosciences group
Read More
New 3-pyridyl-4-arylpyrroles useful for inflammatory and AIDS-related disorders
Read More
Important advances in the Lundbeck pipeline during 2000
Read More
Novel heterocyclic compounds with broad pharmacological activity described by P&G
Read More
Roche presents new imidazodiazepine derivative with advantageous profile
Read More
PGE1 derivatives synthesized at Taisho inhibit vascular smooth muscle cell proliferation
Read More
Potential anticoagulants/antithrombotics under study at Yamanouchi
Read More
Bradycardic tetrahydroisoquinolines prepared by Yamanouchi research team
Read More